swiss managed account

NPS Pharmaceuticals Jumps On Study On Short Bowel Syndrome Drug

NPS Pharmaceuticals (NPSP) has raced higher throughout most of the first three hours of trading. The buying interest comes after the company initiated a phase 3 “STEPS” study to confirm GATTEX reduces paternal nutrition dependence in short bowel syndrome.